Trial Profile

A Phase III clinical trial of ASC42

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 19 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ASC 42 (Primary)
Indications Primary biliary cirrhosis
Focus Pharmacokinetics
Sponsors Gannex Pharma

Most Recent Events

15 Aug 2022 According to an Ascletis media release, company intends to initiate after the completion of the ongoing Phase II clinical trial in China.
15 Aug 2022 According to an Ascletis media release, the DDI study and ongoing Phase II clinical trial in PBC patients in China will provide more evidence to support this study.
29 Nov 2021 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com